Novartis (Bangladesh) Limited has announced that its valsartan brands - Diovan®, CoDiovan®, Entresto® and Exforge® - are not affected by the recent Valsartan recall, says a statement.
Novartis wants to assure general public, healthcare professionals and other concerned stakeholders that the four valsartan brands, marketed in Bangladesh, are produced using its own research-based 'innovator valsartan' API, which is not affected.
The statement said Novartis produces its research based API for Valsartan only at its own manufacturing plants based in Switzerland and England, maintaining the highest level of quality.
Recent recall of valsartan is being done in 23 countries because an impurity was found during qualification tests of generic valsartan API (Active Pharmaceutical Ingredient) were manufactured by a certain Chinese third party manufacturer, it said.
The impurity was identified as N-Nitrosodimethylamine (NDMA).
Novartis wants to reassure its stakeholders that the physicians and patients can use the mentioned medicines confidently, it added.
Source: http://today.thefinancialexpress.com.bd/trade-market/recall-doesnt-affect-valsartan-brands-1532457395
কোন মন্তব্য নেই:
একটি মন্তব্য পোস্ট করুন